|
1
|
Mattox AK, Bettegowda C, Zhou S,
Papadopoulos N, Kinzler KW and Vogelstein B: Applications of liquid
biopsies for cancer. Sci Transl Med. 11(eaay1984)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mader S and Pantel K: Liquid biopsy:
Current status and future perspectives. Oncol Res Treat.
40:404–408. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vanharanta S and Massague J: Origins of
metastatic traits. Cancer Cell. 24:410–421. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rossi E and Zamarchi R: Single-cell
analysis of circulating tumor cells: How far have we come in
the-omics era? Front Genet. 10(958)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ljungberg B, Albiges L, Abu-Ghanem Y,
Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F,
Hora M, Kuczyk MA, et al: European association of urology
guidelines on renal cell carcinoma: The 2019 update. Eur Urol.
75:799–810. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hernandez-Yanez M, Heymach JV and Zurita
AJ: Circulating biomarkers in advanced renal cell carcinoma:
Clinical applications. Curr Oncol Rep. 14:221–229. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Curti BD: Renal cell carcinoma. JAMA.
292:97–100. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Belldegrun AS, Klatte T, Shuch B,
LaRochelle JC, Miller DC, Said JW, Riggs SB, Zomorodian N,
Kabbinavar FF, Dekernion JB and Pantuck AJ: Cancer-specific
survival outcomes among patients treated during the cytokine era of
kidney cancer (1989-2005): A benchmark for emerging targeted cancer
therapies. Cancer. 113:2457–2463. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dabestani S, Thorstenson A, Lindblad P,
Harmenberg U, Ljungberg B and Lundstam S: Renal cell carcinoma
recurrences and metastases in primary non-metastatic patients: A
population-based study. World J Urol. 34:1081–1086. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Klatte T, Rossi SH and Stewart GD:
Prognostic factors and prognostic models for renal cell carcinoma:
A literature review. World J Urol. 36:1943–1952. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Finley DS, Pantuck AJ and Belldegrun AS:
Tumor biology and prognostic factors in renal cell carcinoma.
Oncologist. 16 (Suppl 2):S4–S13. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lindgren D, Eriksson P, Krawczyk K,
Nilsson H, Hansson J, Veerla S, Sjölund J, Höglund M, Johansson ME
and Axelson H: Cell-type-specific gene programs of the normal human
nephron define kidney cancer subtypes. Cell Rep. 20:1476–1489.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rathmell WK and Chen S: VHL inactivation
in renal cell carcinoma: Implications for diagnosis, prognosis and
treatment. Expert Rev Anticancer Ther. 8:63–73. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al:
Detection of circulating tumor DNA in early- and late-stage human
malignancies. Sci Transl Med. 6(224ra24)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Maertens Y, Humberg V, Erlmeier F,
Steffens S, Steinestel J, Bögemann M, Schrader AJ and Bernemann C:
Comparison of isolation platforms for detection of circulating
renal cell carcinoma cells. Oncotarget. 8:87710–87717.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Klezl P, Pospisilova E, Kolostova K,
Sonsky J, Maly O, Grill R, Pawlak I and Bobek V: Detection of
circulating tumor cells in renal cell carcinoma: Disease Stage
Correlation and Molecular Characterization. J Clin Med.
9(1372)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J,
Jing Y, Sun H, Yu F, Zhao L, et al: Combined cell surface carbonic
anhydrase 9 and CD147 antigens enable high-efficiency capture of
circulating tumor cells in clear cell renal cell carcinoma
patients. Oncotarget. 7:59877–59891. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chudasama D, Katopodis P, Stone N, Haskell
J, Sheridan H, Gardner B, Urnovitz H, Schuetz E, Beck J, Hall M, et
al: Liquid biopsies in lung cancer: Four emerging technologies and
potential clinical applications. Cancers (Basel).
11(331)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rizzo MI, Ralli M, Nicolazzo C, Gradilone
A, Carletti R, Di Gioia C, De Vincentiis M and Greco A: Detection
of circulating tumor cells in patients with laryngeal cancer using
ScreenCell: Comparative pre- and post-operative analysis and
association with prognosis. Oncol Lett. 19:4183–4188.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lee Y, Guan G and Bhagat AA: ClearCell(R)
FX, a label-free microfluidics technology for enrichment of viable
circulating tumor cells. Cytometry A. 93:1251–1254. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu L, Mao X, Imrali A, Syed F, Mutsvangwa
K, Berney D, Cathcart P, Hines J, Shamash J and Lu YJ: Optimization
and evaluation of a novel size based circulating tumor cell
isolation system. PLoS One. 10(e0138032)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hansson J, Lindgren D, Nilsson H,
Johansson E, Johansson M, Gustavsson L and Axelson H:
Overexpression of functional SLC6A3 in clear cell renal cell
carcinoma. Clin Cancer Res. 23:2105–2115. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43(e47)2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nacer DF, Liljedahl H, Karlsson A,
Lindgren D and Staaf J: Pan-cancer application of a
lung-adenocarcinoma-derived gene-expression-based prognostic
predictor. Brief Bioinform. 22(bbab154)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen F, Zhang Y, Senbabaoglu Y, Ciriello
G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E,
et al: Multilevel Genomics-Based taxonomy of renal cell carcinoma.
Cell Rep. 14:2476–2489. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kroneis T, Jonasson E, Andersson D,
Dolatabadi S and Stahlberg A: Global preamplification simplifies
targeted mRNA quantification. Sci Rep. 7(45219)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cappelletti V, Verzoni E, Ratta R, Vismara
M, Silvestri M, Montone R, Miodini P, Reduzzi C, Claps M, Sepe P,
et al: Analysis of single circulating tumor cells in renal cell
carcinoma reveals phenotypic heterogeneity and genomic alterations
related to progression. Int J Mol Sci. 21(1475)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pastorekova S and Gillies RJ: The role of
carbonic anhydrase IX in cancer development: Links to hypoxia,
acidosis, and beyond. Cancer Metastasis Rev. 38:65–77.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Thul PJ, Akesson L, Wiking M, Mahdessian
D, Geladaki A, Ait Blal H, Alm T, Asplund A, Björk L, Breckels LM,
et al: A subcellular map of the human proteome. Science.
356(eaal3321)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen J, Cheung F, Shi R, Zhou H and Lu W:
CHI Consortium. PBMC fixation and processing for Chromium
single-cell RNA sequencing. J Transl Med. 16(198)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Neumann MHD, Bender S, Krahn T and
Schlange T: ctDNA and CTCs in Liquid Biopsy-current status and
where we need to progress. Comput Struct Biotechnol J. 16:190–195.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gradilone A, Iacovelli R, Cortesi E,
Raimondi C, Gianni W, Nicolazzo C, Petracca A, Palazzo A, Longo F,
Frati L and Gazzaniga P: Circulating tumor cells and ‘suspicious
objects’ evaluated through CellSearch® in metastatic renal cell
carcinoma. Anticancer Res. 31:4219–4221. 2011.PubMed/NCBI
|
|
35
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells: A new method for
the immunomorphological and molecular characterization of
circulatingtumor cells. Am J Pathol. 156:57–63. 2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
El-Heliebi A, Kroneis T, Zohrer E,
Haybaeck J, Fischereder K, Kampel-Kettner K, Zigeuner R, Pock H,
Riedl R, Stauber R, et al: Are morphological criteria sufficient
for the identification of circulating tumor cells in renal cancer?
J Transl Med. 11(214)2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lindgren D, Sjolund J and Axelson H:
Tracing renal cell carcinomas back to the nephron. Trends Cancer.
4:472–484. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Knepper M and Burg M: Organization of
nephron function. Am J Physiol. 244:F579–F589. 1983.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital Organs-Part A: Renal, Penile, and
Testicular Tumours. Eur Urol. 70:93–105. 2016.PubMed/NCBI View Article : Google Scholar
|
